Radiolabeled Nanoparticles for Multimodality Tumor Imaging

Each imaging modality has its own unique strengths. Multimodality imaging, taking advantages of strengths from two or more imaging modalities, can provide overall structural, functional, and molecular information, offering the prospect of improved diagnostic and therapeutic monitoring abilities. The devices of molecular imaging with multimodality and multifunction are of great value for cancer diagnosis and treatment, and greatly accelerate the development of radionuclide-based multimodal molecular imaging. Radiolabeled nanoparticles bearing intrinsic properties have gained great interest in multimodality tumor imaging over the past decade. Significant breakthrough has been made toward the development of various radiolabeled nanoparticles, which can be used as novel cancer diagnostic tools in multimodality imaging systems. It is expected that quantitative multimodality imaging with multifunctional radiolabeled nanoparticles will afford accurate and precise assessment of biological signatures in cancer in a real-time manner and thus, pave the path towards personalized cancer medicine. This review addresses advantages and challenges in developing multimodality imaging probes by using different types of nanoparticles, and summarizes the recent advances in the applications of radiolabeled nanoparticles for multimodal imaging of tumor. The key issues involved in the translation of radiolabeled nanoparticles to the clinic are also discussed.

[1]  V. Torchilin,et al.  Structure and design of polymeric surfactant-based drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Yun Sun,et al.  Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. , 2010, Biomaterials.

[3]  Xin Gao,et al.  Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy. , 2011, Biomaterials.

[4]  Heiko Schöder,et al.  Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. , 2009, Seminars in nuclear medicine.

[5]  Chenjie Xu,et al.  PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.

[6]  P. Conti,et al.  Target-specific delivery of peptide-based probes for PET imaging. , 2010, Advanced drug delivery reviews.

[7]  El Sayed SOME INTERESTING PROPERTIES OF METALS CONFINED IN TIME AND NANOMETER SPACE OF DIFFERENT SHAPES , 2001 .

[8]  P. Artymiuk,et al.  Evidence that a salt bridge in the light chain contributes to the physical stability difference between heavy and light human ferritins. , 1992, The Journal of biological chemistry.

[9]  S. Santra Fluorescent silica nanoparticles for cancer imaging. , 2010, Methods in molecular biology.

[10]  Vincent Noireaux,et al.  In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.

[11]  E. Even-Sapir,et al.  Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  Weibo Cai,et al.  Multimodality Molecular Imaging of Tumor Angiogenesis , 2008, Journal of Nuclear Medicine.

[13]  Ralph Weissleder,et al.  Hybrid In Vivo FMT-CT Imaging of Protease Activity in Atherosclerosis With Customized Nanosensors , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Vladimir P Torchilin,et al.  Current trends in liposome research. , 2010, Methods in molecular biology.

[15]  P. Conti,et al.  Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression. , 2010, Bioconjugate chemistry.

[16]  M. G. Finn,et al.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions. , 2001, Angewandte Chemie.

[17]  Xiaoyuan Chen,et al.  Design and development of molecular imaging probes. , 2010, Current topics in medicinal chemistry.

[18]  C. Anderson,et al.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. , 2010, Chemical reviews.

[19]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[20]  S R Cherry,et al.  Optical imaging of Cerenkov light generation from positron-emitting radiotracers , 2009, Physics in medicine and biology.

[21]  V. Torchilin,et al.  Micellar Nanocarriers: Pharmaceutical Perspectives , 2006, Pharmaceutical Research.

[22]  N. Willich,et al.  FDG-PET/CT in oncology , 2007, Nuklearmedizin.

[23]  Hao Hong,et al.  Molecular imaging and therapy of cancer with radiolabeled nanoparticles. , 2009, Nano today.

[24]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[25]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[26]  Grant T Gullberg,et al.  Dynamic single photon emission computed tomography—basic principles and cardiac applications , 2010, Physics in medicine and biology.

[27]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.

[28]  Lev Dykman,et al.  Analytical and Theranostic Applications of Gold Nanoparticles and Multifunctional Nanocomposites , 2013, Theranostics.

[29]  Marcelino Bernardo,et al.  A dendrimer‐based nanosized contrast agent dual‐labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice , 2007, Journal of magnetic resonance imaging : JMRI.

[30]  Jun Lin,et al.  Up-conversion cell imaging and pH-induced thermally controlled drug release from NaYF4/Yb3+/Er3+@hydrogel core-shell hybrid microspheres. , 2012, ACS nano.

[31]  J H Senior,et al.  Fate and behavior of liposomes in vivo: a review of controlling factors. , 1987, Critical reviews in therapeutic drug carrier systems.

[32]  Shuang Liu,et al.  99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals , 1999 .

[33]  Hatem Fessi,et al.  Theranostic applications of nanoparticles in cancer. , 2012, Drug discovery today.

[34]  Angelique Louie,et al.  Multimodality imaging probes: design and challenges. , 2010, Chemical reviews.

[35]  A. Scarsbrook,et al.  FDG PET/CT in oncology: "raising the bar". , 2010, Clinical radiology.

[36]  Fan Zhang,et al.  Chimeric ferritin nanocages for multiple function loading and multimodal imaging. , 2011, Nano letters.

[37]  Yeong Su Ha,et al.  Facile preparation of a hybrid nanoprobe for triple-modality optical/PET/MR imaging. , 2010, Small.

[38]  Paul Kinahan,et al.  A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  Akshay Anand,et al.  raising the bar , 2010, Annals of neurosciences.

[40]  R. Weissleder,et al.  Hybrid PET-optical imaging using targeted probes , 2010, Proceedings of the National Academy of Sciences.

[41]  Jason S. Lewis,et al.  Unconventional Nuclides for Radiopharmaceuticals , 2010, Molecular imaging.

[42]  S. Cherry,et al.  Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[43]  U. Häfeli,et al.  Evaluation of (111)In labeled antibodies for SPECT imaging of mesothelin expressing tumors. , 2011, Nuclear medicine and biology.

[44]  M. Ferrari Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[45]  Xueyuan Chen,et al.  Upconversion nanoparticles in biological labeling, imaging, and therapy. , 2010, The Analyst.

[46]  Khaled Greish,et al.  Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. , 2010, Methods in molecular biology.

[47]  Shuang Liu,et al.  99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals. , 1999, Chemical reviews.

[48]  U. Gösele,et al.  Reducing stress on cells with apoferritin-encapsulated platinum nanoparticles. , 2010, Nano letters.

[49]  Nicholas J Long,et al.  'Two is better than one'--probes for dual-modality molecular imaging. , 2009, Chemical communications.

[50]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[51]  N. Khlebtsov,et al.  Gold nanoparticles in biomedical applications: recent advances and perspectives. , 2012, Chemical Society reviews.

[52]  Seulki Lee,et al.  Dual-Modality Probes for in Vivo Molecular Imaging , 2009, Molecular imaging.

[53]  T. Douglas,et al.  Iron and cobalt oxide and metallic nanoparticles prepared from ferritin. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[54]  N. Van Rooijen,et al.  Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. , 1994, Biochimica et biophysica acta.

[55]  Tymish Y. Ohulchanskyy,et al.  High contrast in vitro and in vivo photoluminescence bioimaging using near infrared to near infrared up-conversion in Tm3+ and Yb3+ doped fluoride nanophosphors. , 2008, Nano letters.

[56]  Kai Chen,et al.  PET/NIRF/MRI triple functional iron oxide nanoparticles. , 2010, Biomaterials.

[57]  Marcus Textor,et al.  Stabilization and functionalization of iron oxide nanoparticles for biomedical applications. , 2011, Nanoscale.

[58]  Sailing He,et al.  Quantum rod bioconjugates as targeted probes for confocal and two-photon fluorescence imaging of cancer cells. , 2007, Nano letters.

[59]  Yi Wang,et al.  Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle. , 2010, Bioconjugate chemistry.

[60]  Sang Moo Lim,et al.  RGD Peptide–Conjugated Multimodal NaGdF4:Yb3+/Er3+ Nanophosphors for Upconversion Luminescence, MR, and PET Imaging of Tumor Angiogenesis , 2013, The Journal of Nuclear Medicine.

[61]  W. Lu,et al.  Annexin A5–Conjugated Polymeric Micelles for Dual SPECT and Optical Detection of Apoptosis , 2011, The Journal of Nuclear Medicine.

[62]  Sung Ho Ryu,et al.  A Nucleolin-Targeted Multimodal Nanoparticle Imaging Probe for Tracking Cancer Cells Using an Aptamer , 2010, Journal of Nuclear Medicine.

[63]  Jun Wang,et al.  Protein-based nanomedicine platforms for drug delivery. , 2009, Small.

[64]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[65]  Ron C. Hardman A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors , 2005, Environmental health perspectives.

[66]  P. Conti,et al.  Strain-Promoted Catalyst-Free Click Chemistry for Rapid Construction of (64)Cu-Labeled PET Imaging Probes. , 2012, ACS medicinal chemistry letters.

[67]  J. Panda,et al.  The present and future of nanotechnology in human health care. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[68]  M. Young,et al.  Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. , 2006, Journal of the American Chemical Society.

[69]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[70]  M Cheki,et al.  Marvelous applications of quantum dots. , 2013, European review for medical and pharmacological sciences.

[71]  A. Rehemtulla,et al.  Molecular Imaging , 2009, Methods in Molecular Biology.

[72]  S. Cherry Multimodality in vivo imaging systems: twice the power or double the trouble? , 2006, Annual review of biomedical engineering.

[73]  Jaymes R Beech,et al.  Targeted nanoparticles in imaging: paving the way for personalized medicine in the battle against cancer. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[74]  Henri Szwarc,et al.  Toxicity studies of carbon nanotubes. , 2007, Advances in experimental medicine and biology.

[75]  D. Shin,et al.  The medicinal chemistry of theragnostics, multimodality imaging and applications of nanotechnology in cancer. , 2010, Current topics in medicinal chemistry.

[76]  P. Choyke,et al.  Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. , 2007, Bioconjugate chemistry.

[77]  M. El-Sayed,et al.  Some interesting properties of metals confined in time and nanometer space of different shapes. , 2001, Accounts of chemical research.

[78]  Jun Lin,et al.  Functionalized mesoporous silica materials for controlled drug delivery. , 2012, Chemical Society reviews.

[79]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[80]  Kai Chen,et al.  Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[81]  Robert Blumenthal,et al.  Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. , 2009, Critical reviews in therapeutic drug carrier systems.

[82]  Jun Lin,et al.  Synthesis of Magnetic, Up‐Conversion Luminescent, and Mesoporous Core–Shell‐Structured Nanocomposites as Drug Carriers , 2010 .

[83]  Simon R Cherry,et al.  Multimodality imaging: beyond PET/CT and SPECT/CT. , 2009, Seminars in nuclear medicine.

[84]  K. Hirata,et al.  Process of accumulation of metal ions on the interior surface of apo-ferritin: crystal structures of a series of apo-ferritins containing variable quantities of Pd(II) ions. , 2009, Journal of the American Chemical Society.

[85]  Ick Chan Kwon,et al.  Multifunctional nanoparticles for multimodal imaging and theragnosis. , 2012, Chemical Society reviews.

[86]  Karen L Wooley,et al.  64Cu Core-labeled nanoparticles with high specific activity via metal-free click chemistry. , 2012, ACS nano.

[87]  C. Anderson,et al.  Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). , 2009, Accounts of chemical research.

[88]  Antony D. Gee,et al.  Synthesis of 11 C , 18 F , 15 O , and 13 N Radiolabels for Positron Emission Tomography , 2008 .

[89]  L. Tei,et al.  Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe. , 2006, Cancer research.

[90]  Nicholas J Long,et al.  Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. , 2008, Angewandte Chemie.

[91]  Hak Soo Choi,et al.  Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation , 2010, Molecular imaging.

[92]  Sanjiv S. Gambhir,et al.  Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature , 2007, Journal of Nuclear Medicine.

[93]  Lev Dykman,et al.  Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. , 2011, Chemical Society reviews.

[94]  T. Allen,et al.  Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.

[95]  Jinwoo Cheon,et al.  A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. , 2008, Angewandte Chemie.

[96]  Hisataka Kobayashi,et al.  Dendrimer-based contrast agents for molecular imaging. , 2008, Current topics in medicinal chemistry.

[97]  D. Meier,et al.  Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[98]  P. Conti,et al.  An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals. , 2010, Nuclear medicine and biology.

[99]  H. Kolb,et al.  The growing impact of click chemistry on drug discovery. , 2003, Drug discovery today.

[100]  W. Oyen,et al.  Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. , 2001, The Journal of pharmacology and experimental therapeutics.

[101]  P. Jacobs,et al.  Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.

[102]  Chenjie Xu,et al.  Commercial Nanoparticles for Stem Cell Labeling and Tracking , 2013, Theranostics.

[103]  Thomas D. Wang,et al.  Exogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-modal Imaging , 2010, Cancers.